Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide

被引：0
|
作者：
Schuelper, Nikolai [1 ]
Flohr, Antonius [2 ]
Truemper, Lorenz [1 ]
Wulf, Gerald G. [1 ]
机构：
[1] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Dept Radiol, D-37075 Gottingen, Germany
来源：
ANNALS OF HEMATOLOGY | 2014年 / 93卷 / 11期
关键词：
MONOTHERAPY;
D O I：
10.1007/s00277-014-2071-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1929 / 1930
页数：2
相关论文
共 38 条
  • [1] Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello, Patrizia
    Steiner, Normann
    Willenbacher, Wolfgang
    Ferrero, Simone
    Ghione, Paola
    Marabese, Alessandra
    Pitini, Vincenzo
    Cuzzocrea, Salvatore
    Mian, Michael
    ONCOLOGIST, 2016, 21 (09) : 1107 - 1112
  • [2] Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice
    Broccou, Alessandro
    Casadei, Beatrice
    Chiappella, Annalisa
    Visco, Carlo
    Tani, Monica
    Cascavilla, Nicola
    Conconi, Annarita
    Balzarotti, Monica
    Cox, Maria Christina
    Marino, Dario
    Goldaniga, Maria Ceolia
    Marasca, Roberto
    Tecchio, Cristina
    Patti, Caterina
    Musuraca, Gerardo
    Devizzi, Liuana
    Monaco, Federico
    Romano, Alessandra
    Fama, Angelo
    Zancanella, Michelle
    Paolini, Rossella
    Rigacci, Luigi
    Castellino, Claudia
    Gaudio, Francesco
    Argnani, Lisa
    Zinzani, Pier Luigi
    ONCOLOGIST, 2019, 24 (09) : 1246 - 1252
  • [3] Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients
    Nikolett, Wohner
    Gergely, Varga
    Peter, Szloboda
    Peter, Farkas
    Andras, Masszi
    Laura, Horvath
    Gergely, Szombath
    Judit, Varkonyi
    Szabolcs, Benedek
    Tamas, Masszi
    ORVOSI HETILAP, 2017, 158 (41) : 1642 - 1648
  • [4] Application of Lenalidomide on Diffused Large B-cell Lymphoma: Salvage, Maintenance, and Induction Treatment
    Ma, Li-Yangxue
    Su, Li
    CHINESE MEDICAL JOURNAL, 2018, 131 (20) : 2510 - 2513
  • [5] Lenalidomide demonstrates clinical activity in anaplastic lymphoma kinase-positive large B-cell lymphoma
    Bhaskar, Shakthi
    Abro, Brooj
    Fraum, Tyler J.
    Mehta-Shah, Neha
    BMJ CASE REPORTS, 2020, 13 (08)
  • [6] Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression
    Zhang, Ling-Hua
    Kosek, Jolanta
    Wang, Maria
    Heise, Carla
    Schafer, Peter H.
    Chopra, Rajesh
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (04) : 487 - 502
  • [7] Rituximab-lenalidomide-dexamethasone induces complete and durable remission in relapsed refractory diffuse large B-cell non-Hodgkin lymphoma
    Ivanov, Vadim
    Tabouret, Emeline
    Chuto, Guillaume
    Chetaille, Bruno
    Fezoui, Hacene
    Coso, Diane
    Rey, Jerome
    Aurran-Schleinitz, Therese
    Schiano, Jean Marc
    Stoppa, Anne Marie
    Blaise, Didier
    Bouabdallah, Reda
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1758 - 1760
  • [8] Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type
    Fenot, Marion
    Quereux, Gaelle
    Brocard, Anabelle
    Renaut, Jean-Jacques
    Dreno, Brigitte
    EUROPEAN JOURNAL OF DERMATOLOGY, 2010, 20 (06) : 753 - 757
  • [9] Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
    Cox, Maria Christina
    Mannino, Giuseppe
    Lionetto, Luana
    Naso, Virginia
    Simmaco, Maurizio
    Spiriti, Maria Antonietta Aloe
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (11) : 957 - 957
  • [10] Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma
    Salles, Gilles
    Gopal, Ajay K.
    Minnema, Monique C.
    Wakamiya, Karen
    Feng, Huaibao
    Schecter, Jordan M.
    Wang, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05) : 275 - 284
1234